Another study of 3 adults diagnosed with invasive breast cancer in whom BRCA1 or BRCA2 mutations were identified and then returned also showed mixed reactions, including some guilt, although one year after confirmatory testing all of the interviewees considered that there were more advantages than disadvantages to receiving the information [202]. The gene discussed is BRCA2; the disease is invasive breast carcinoma.